Novel cancer stem cell marker MVP enhances temozolomide-resistance in glioblastoma

Novel cancer stem cell marker MVP enhances temozolomide-resistance in glioblastoma

The resistance of highly aggressive glioblastoma multiforme (GBM) to chemotherapy is a major clinical problem resulting in a poor prognosis. GBM contains a rare population of self-renewing cancer stem cells (CSCs) that proliferate, spurring the growth of new tumors, and evade chemotherapy. In cancer...

Full description

Bibliographic Details
Main Authors: Kum Hee Noh, Song-Hee Lee, Haeri Lee, Ae Jin Jeong, Kyu Oh Kim, Hyun Mu Shin, Hang-Rae Kim, Myung-Jin Park, Jong Bae Park, Jiyoung Lee, Sang-Kyu Ye
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Translational Oncology
Subjects:
Cancer stem cells
Glioblastoma
Major vault protein
Tumorsphere
Temozolomide
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523321002448

Internet

http://www.sciencedirect.com/science/article/pii/S1936523321002448

Similar Items